Cubist Systematic Strategies’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-32,834
| Closed | -$2.24M | – | 3957 |
|
2022
Q3 | $2.24M | Sell |
32,834
-29,655
| -47% | -$2.02M | 0.01% | 1493 |
|
2022
Q2 | $2M | Buy |
62,489
+51,598
| +474% | +$1.65M | 0.01% | 1582 |
|
2022
Q1 | $377K | Sell |
10,891
-26,899
| -71% | -$931K | ﹤0.01% | 2680 |
|
2021
Q4 | $1.11M | Sell |
37,790
-140,009
| -79% | -$4.1M | 0.01% | 1842 |
|
2021
Q3 | $4.53M | Buy |
177,799
+92,896
| +109% | +$2.37M | 0.06% | 515 |
|
2021
Q2 | $2.97M | Buy |
84,903
+7,269
| +9% | +$255K | 0.03% | 836 |
|
2021
Q1 | $3.16M | Buy |
77,634
+23,095
| +42% | +$941K | 0.04% | 714 |
|
2020
Q4 | $2.36M | Buy |
54,539
+21,347
| +64% | +$925K | 0.03% | 845 |
|
2020
Q3 | $1.83M | Sell |
33,192
-18,295
| -36% | -$1.01M | 0.03% | 965 |
|
2020
Q2 | $3.25M | Buy |
51,487
+32,906
| +177% | +$2.08M | 0.06% | 539 |
|
2020
Q1 | $949K | Sell |
18,581
-4,668
| -20% | -$238K | 0.03% | 869 |
|
2019
Q4 | $1.85M | Buy |
23,249
+10,144
| +77% | +$806K | 0.03% | 794 |
|
2019
Q3 | $636K | Sell |
13,105
-4,257
| -25% | -$207K | 0.01% | 1179 |
|
2019
Q2 | $913K | Buy |
+17,362
| New | +$913K | 0.02% | 1099 |
|
2018
Q4 | – | Sell |
-9,410
| Closed | -$358K | – | 2332 |
|
2018
Q3 | $358K | Buy |
9,410
+1,308
| +16% | +$49.8K | 0.02% | 1032 |
|
2018
Q2 | $366K | Buy |
+8,102
| New | +$366K | 0.02% | 959 |
|
2018
Q1 | – | Sell |
-733
| Closed | -$29K | – | 2143 |
|
2017
Q4 | $29K | Sell |
733
-5,786
| -89% | -$229K | ﹤0.01% | 1823 |
|
2017
Q3 | $202K | Sell |
6,519
-1,686
| -21% | -$52.2K | 0.01% | 1439 |
|
2017
Q2 | $224K | Buy |
8,205
+3,991
| +95% | +$109K | 0.01% | 1223 |
|
2017
Q1 | $155K | Buy |
+4,214
| New | +$155K | 0.01% | 1278 |
|
2016
Q2 | – | Sell |
-5,665
| Closed | -$90K | – | 1935 |
|
2016
Q1 | $90K | Buy |
+5,665
| New | +$90K | 0.01% | 1412 |
|